Cynthia Dunleavy
Surgical · Anchorage, AKNPI 1710406822
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $851 and has fallen 66.7% since, to $283 in 2025.
Across 66 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$248
- Amgen$92
- Neurocrine Biosciences, Inc.$89
- Pfizer$86
- Lundbeck LLC$76
- Sanofi$71
- plus $744 from 22 others
What the payments were for
- Food & beverage$1,407100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $248 |
| Amgen | 3 | $92 |
| Neurocrine Biosciences, Inc. | 6 | $89 |
| Pfizer | 4 | $86 |
| Lundbeck LLC | 4 | $76 |
| Sanofi | 3 | $71 |
| Biohaven Pharmaceuticals, Inc. | 3 | $68 |
| EMD Serono, Inc. | 3 | $58 |
| Globus Medical | 1 | $51 |
| Merz Pharmaceuticals, LLC | 2 | $44 |
| Akcea Therapeutics, Inc. | 2 | $43 |
| Biogen | 2 | $42 |
| AstraZeneca | 3 | $41 |
| Avanos Medical | 2 | $40 |
| Averitas Pharma Inc. | 2 | $39 |
| Novartis | 2 | $37 |
| Neurelis, Inc. | 2 | $37 |
| Tersera Therapeutics LLC | 1 | $33 |
| Medtronic | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| SK Life Science, Inc. | 1 | $22 |
| Livanova USA, Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
How this compares
$1,407 in reported general payments places this provider in the 65th percentile of 31 surgical providers in Alaska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclobenzaprine Hcl | 16 | $537 |
Paid to pharmacies, not to this prescriber.
Other surgical in Anchorage
- Candace HickelAnchorage$12K
- Susan HartmannAnchorage$5K
- Cheukyin PangAnchorage$3K
- Jayme FullerAnchorage$3K
- Kristina EllisAnchorage$2K
- Michael Thruangsnga-KentAnchorage$2K
- Brenton StockwellAnchorage$1K
- Kaleigh BishopAnchorage$1K
- Benjamin KennahAnchorage$972
- Marie TaylorAnchorage$805
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.